Condition
High Grade Dysplasia
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
60.0%
-26.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results60% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Terminated2
Trial Success Rate
60.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02396745Not ApplicableTerminated
TECR & ECM Placement for Esophageal High Grade Dysplasia
NCT00587600Phase 2Completed
Biomarkers in Phototherapy of Barrett's Esophagus
NCT00586989Completed
Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus
NCT00526786Phase 4Terminated
Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
NCT01236443Phase 1Completed
Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
Showing all 5 trials